BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals Selling, General & Admin

Explore Anthera Pharmaceuticals's selling, general & admin with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$3.50M
20.67% YoY

As of Mar 31, 2018

Annual SG&A Expenses (TTM)

$8.54M
27.26% YoY

Trailing 12 months ending Mar 31, 2018

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Anthera Pharmaceuticals (ANTH) FAQ

Stockcircle tracks selling, general & admin for Anthera Pharmaceuticals (ANTH), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Anthera Pharmaceuticals's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ANTH overview so you can move from this figure to the surrounding analysis quickly.